Table 4.
|
Receiving ARTa |
Adherenceb |
Viral suppressiona |
|||
---|---|---|---|---|---|---|
Patient race | n (%) | OR (95% CI) | n (%) | OR (95% CI) | n (%) | OR (95% CI) |
Whites | 323 (92) | — | 287 (89) | — | 164 (47) | — |
African Americans, complete trust in provider | 1,193 (86) | 0.59 (0.37–0.94) | 1,023 (86) | 0.59 (0.36–0.95) | 561 (40) | 0.77 (0.58–1.0) |
African Americans, incomplete trust in provider | 619 (83) | 0.59c (0.36–0.96) | 487 (79) | 0.40d (0.25–0.66) | 287 (38) | 0.71c (0.52–0.97) |
ART, antiretroviral therapy; OR, odds ratio for comparison with whites; CI, confidence interval.
Adjusted for age, sex, sexual preference, history of injection drug use, and overall quality of life.
Among patients receiving ART or with CD4 count ≤350 cells/mm3.
Among patients receiving ART.
p = NS for comparison to African Americans with complete trust in provider.
p = 0.009 (adjusted OR, 0.69; 95% CI, 0.52–0.91) for comparison with African Americans with complete trust in provider.